Recovery.com Acquires RedFox AI to Boost AI Capabilities
Recovery.com has acquired RedFox AI to enhance its AI capabilities in mental health and addiction treatment, announced in a press release.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Recovery.com has acquired RedFox AI to enhance its AI capabilities in mental health and addiction treatment, announced in a press release.
RamSoft and Therapixel have announced a partnership to integrate AI-powered breast imaging solutions into RamSoft's platforms, enhancing cancer detection and radiologist workflows.
Fine-tuned large language models (LLMs) have shown significant potential in improving error detection in radiology reports, according to a recent study published in Radiology. The study highlights the effectiveness of models like GPT-4 and Llama-3-70B-Instruct in identifying errors in chest x-ray reports.
ProgenyHealth has announced a significant growth investment from Cressey & Company and existing investor Sunstone Partners to expand its maternity and NICU care services.
Rad AI has announced an additional $8 million investment from four major health systems, bringing its Series C funding to $68 million.
PHASE Scientific has raised $34 million in a Series A funding round to advance its urine-based diagnostic technology for early disease detection, announced in a press release.
SIME Diagnostics has announced the results of a clinical study on its AI-powered Lung Maturity Test for late-preterm newborns, conducted in collaboration with Mayo Clinic.
UCB and Domino Data Lab have announced a collaboration to modernize the Statistical Computing Environment for life sciences, integrating advanced cloud technologies and data science tools.
Lunit has achieved a significant milestone by surpassing one million mammograms in the U.S., a year after acquiring Volpara Health, according to a press release.
Cortechs.ai and ALZ-NET have announced a strategic collaboration to enhance Alzheimer's disease care using AI-driven imaging technology.
IMVARIA has presented its AI-powered diagnostic service, Fibresolve, at the ATS 2025 Conference, highlighting its use in diagnosing lung diseases like Idiopathic Pulmonary Fibrosis.
Royal Philips' Future Health Index 2025 report emphasizes AI's transformative potential in healthcare, while highlighting trust gaps among clinicians and patients as a barrier to adoption.
Oracle, Cleveland Clinic, and G42 have announced a strategic partnership to develop an AI-based global healthcare delivery platform, aiming to enhance patient care and public health management.
Brainomix has presented new studies validating its e-Lung technology for identifying progressive pulmonary fibrosis, in collaboration with Boehringer Ingelheim.
Dentegrate AI is transforming dental practice growth by automating patient acquisition and engagement, leading to significant increases in new patient numbers.
MediKarma has announced its alignment with the CMS Innovation Center's strategy to enhance preventive healthcare through AI, focusing on personalized, real-time wellness guidance.
The global AI in Life Science Analytics Market is projected to grow from $1.9 billion in 2024 to $3.6 billion by 2030, driven by advancements in AI and machine learning.
Akido Labs has raised $60 million in Series B funding to expand its AI healthcare system, ScopeAI, enhancing clinical capacity and access to care.
Axtria and Genloop have teamed up to deliver domain-trained large language models (LLMs) for the life sciences industry, enhancing AI solutions with improved accuracy and flexibility.
Vetsie has partnered with the Merck Veterinary Manual to integrate its trusted content into Vetsie's AI-driven platform, enhancing clinical decision-making for veterinary professionals.